Recent Comments
- LB on The final House report on COVID
- Joy Smith on The Declaration of Pandemics
- Linnea Comstock on The Declaration of Pandemics
- Lance W Richardson on The Declaration of Pandemics
- Sarah on The Declaration of Pandemics
Most Viewed Posts
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (23,620)
- Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA (17,647)
- New treatment paradigm for C. Diff colitis (16,051)
- The Healthcare Channel hits 10 (15,505)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (15,302)
- How the FDA regulates compounding pharmacies (15,132)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (14,979)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (10,949)
- The new CDC guidelines for prescribing opioid pain pills (10,420)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (10,282)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Nutrition
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: Z Medical centers
anti-PD1 and anti-PD-L1 drugs treating NSCLC
March 26, 2013 Interviewed By Steven E. Greer, MD
Posted in - Biotech, - Pharma, Oncology, UCLA
Leave a comment
The Damon Runyon Cancer Research Foundation panel
March 8, 2013 By Steven E. Greer, MD We interviewed three of the oncologists and industry executives who spoke at the Damon Runyon
Posted in - Biotech, - Pharma, Harvard, Oncology
Leave a comment
The IOM report on counterfeit and substandard drugs
Prashant Yadav, PhD, Director, Health Care Research Initiative, University of Michigan, discusses
Posted in - Policy, Univ Michigan
Leave a comment
Double arm transplantation
Gerald Brandacher, MD, Scientific Director of the Composite Tissue Allotransplantation (Reconstructive Transplant) Program at Johns Hopkins discusses the first double arm transplant.
Posted in Johns Hopkins, Plastic surgery
Leave a comment
New therapies for Multiple Sclerosis
Interviewed by Steven E. Greer, MD Barbara Giesser, MD, neurologist and Medical Director of the Multiple Sclerosis Center at UCLA, discusses the
Posted in Neurology, UCLA, Uncategorized
Leave a comment
High fructose consumption and fatty liver disease
Manal F. Abdelmalek, MD, MPH, of the Duke Medical Center’s Division of Gastroenterology/Hepatology
Posted in Diabetes and endocrinology, Duke, FDA, Pediatrics
Leave a comment
Will medical centers be able to change leadership structure to conform to the PPACA “ObamaCare”?
June 30, 2012, by Steven Greer, MD The Supreme Court ruled that the PPACA “ObamaCare” law was constitutional in most aspects.
Posted in - Policy, Cardiology, Congress, Univ Maryland
Leave a comment
Does Steve Nissen manipulate the media?
April 5, 2010 Opinion By Steven E. Greer, MD The New York Times recently ran a front-page story raising concern about expanding the indication for statins to people with normal cholesterol levels, per the Crestor JUPITER trial. The article mentioned … Continue reading
Posted in - Opinion, - Policy, Cardiology, Cleveland Clinic
Leave a comment
Reasons to Abandon Low-Density Lipoprotein Cholesterol Targets
Interviewed by Steven Greer, MD Harlan Krumholz, MD, cardiologist from Yale, discusses his open letter in the journal Circulation
Posted in - Policy, Cardiology, CMS, FDA, NIH, Yale
Leave a comment
Steven Greer, MD discusses healthcare jobs, ways to reduce hospital error, and the problems with fee for service
February 22, 2012
Posted in - Policy, Univ Kentucky
Leave a comment
Matthews Chacko, MD: Renal denervation to treat HTN
December 29, 2010 Many medical devices cause a far greater clinical impact than pharmaceutical therapies such
Posted in - Medical Devices, Cardiology, Johns Hopkins
Leave a comment
The CardioMEMS’ heart failure pressure measurement system
By Steven Greer, MD The CardioMEMS’ heart failure pressure measurement system will be evaluated by an FDA
Posted in - Medical Devices, Cardiology, FDA, Ohio State
Leave a comment
Cardiology genomic, stem cell, and interventional research at U. Miami
May 13, 2011- The Healthcare Channel hosted, in conjunction with Mark Schoenebaum of ISI, a tour of the
Posted in Cardiology, Genetics, Univ Miami
Leave a comment
Paul Richardson, MD: Three-drug regimen for multiple myeloma
December 15, 2015 Dr. Paul Richardson of Harvard’s Dana-Farber Cancer Institute reviews the recent Lancet article
Posted in - Biotech, - Pharma, Harvard, Oncology
Leave a comment
Benjamin Sommers, MD PhD: the challenges of expanding Medicaid
November 23, 2010- Interviewed by Steven Greer, MD Under the ACA health insurance reform laws, approximately 16 million new Medicaid patients
Posted in CMS, Harvard
Leave a comment
Will more Medicaid patients stress the system financially?
November 23, 2010- Interviewed by Steven Greer MD Under the ACA health insurance reform laws, approximately 16 million new Medicaid patients
Posted in - Opinion, CMS, Harvard
Leave a comment
Review of the CREST trial of carotid stenting
The CREST trial, published earlier this year, was the latest large-scale, randomized, controlled
Early palliative care improves outcomes in lung cancer patients
August 30, 2010- Produced and interviewed by Steven Greer, MD A group from Harvard published a paper in The NEJM that showed early initiation of palliative
Posted in Harvard, Oncology
Leave a comment
Managing stroke and bleeding with LVAD patients
August 2, 2010- Interviewed by Steven Greer, MD As continuous flow pump LVAD devices are being implanted for longer periods of time in destination
Exclusive: Why did Dr. Nissen resort to secret tapes?
February 23, 2010– By Steven E. Greer, MD Many in the cardiology community are a bit confused as to why Dr. Steven Nissen resorted
Posted in - Opinion, - Policy, Cardiology, Cleveland Clinic, FDA
Leave a comment